Close
Back to SELB Stock Lookup

Selecta Biosciences (SELB) – Hot FDA News

Mar 21, 2023 05:34 AM Selecta Biosciences (SELB) Reports Phase 3 DISSOLVE Program of SEL-212 Met Primary Endpoint
Nov 24, 2021 04:15 PM Selecta Biosciences (SELB) Phase 1/2 Clinical Trial of SEL-302 for the Treatment of Methylmalonic Acidemia Placed on Clinical Hold
Sep 30, 2020 04:28 PM
Oct 17, 2018 04:55 PM
Jun 15, 2017 07:31 AM

Back to SELB Stock Lookup